PCRX - Pacira BioSciences, Inc.
22.86
0 0%
Share volume: 931,883
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$22.86
0.00
0.00%
Summary score
36%
Profitability
26%
Dept financing
14%
Liquidity
70%
Performance
43%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0.05%
Return on assets
0.33%
Return on sales
2.27%
Return on invested capital
-1.3%
Total debt ratio
54.54%
Debt ratio change over timeo
0%
Current Ratio
6.96%
Quick Ratio
6.23%
Cash Position Ratio
1.52%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
5.3%
Return on assets
1.06%
Return on sales
8.16%
Return on invested capital
6.58%
Total debt ratio
54.76%
Debt ratio change over timeo
0%
Current Ratio
5.81%
Quick Ratio
5.06%
Cash Position Ratio
0.99%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
22.25%
Return on assets
1.5%
Return on sales
15.59%
Return on invested capital
27.37%
Total debt ratio
52.09%
Debt ratio change over time
0%
Current Ratio
7.63%
Quick Ratio
6.84%
Cash Position Ratio
1.45%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PCRX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0.05% | 18.71% | 4.67% | -3.65% |
| Return on assets | 0.33% | 3.4% | 3.32% | 3.5% |
| Return on sales | 2.27% | 24.27% | 25.81% | 31.31% |
| Return on invested capital | -1.3% | 5.38% | 4.17% | 4.99% |
| Profitability | 4% | 94% | 70% | 73% |
| Total debt ratio | 54.54% | 78.91% | 58.54% | 101.15% |
| Debt ratio change over time | 0% | 0% | 10.69% | 52.18% |
| Dept financing | 13% | 20% | 20% | 50% |
| Current Ratio | 5.81% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 5.06% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 0.99% | 0.21% | 0.6% | 1.41% |
| Liquididy | 75% | 14% | 20% | 22% |
| Short-term ratios | PCRX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 5.3% | 41.05% | 6.87% | -16.17% |
| Return on assets | 1.06% | 3.67% | 3.13% | 2.71% |
| Return on sales | 8.16% | 26.16% | 24.75% | 29.9% |
| Return on invested capital | 6.58% | 9.43% | 5.58% | 6.54% |
| Profitability | 35% | 97% | 61% | 61% |
| Total debt ratio | 54.76% | 91.28% | 61.3% | 99.31% |
| Debt ratio change over time | 0% | 0% | 13.89% | -24.55% |
| Dept financing | 14% | 23% | 40% | 25% |
| Current Ratio | 5.81% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 5.06% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 0.99% | 0.21% | 0.6% | 1.41% |
| Liquididy | 68% | 14% | 22% | 43% |